scholarly journals Virological and molecular investigation on specimens from buffaloes suspected to be infected by buffalopox virus in Egypt 2019

2021 ◽  
Vol 53 (4) ◽  
Author(s):  
Christine A. Mikhael ◽  
Farid F. Zaki ◽  
Fayez A. Salib

In this study, skin lesions from buffaloes showing clinical signs of buffalopox infection were tested to isolate and identify the buffalopox virus (BPXV). Clinical examination of infected buffaloes was performed and visible clinical signs recorded. Skin scabs from infected buffaloes were collected and used for virus isolation on embryonated chicken egg (ECE) and tissue culture cell lines. The isolated BPXV was identified and characterized using polymerase chain reaction (PCR). The infected buffaloes displayed fever, skin eruptions, enlargement of superficial lymph nodes, emaciation and drop in milk yield. The ECE inoculated with the prepared skin scab samples showed clear raised white pock lesions on the chorioallantoic membrane (CAM). The inoculated tissue cultures (VERO and BHK cell lines) revealed a cytopathic effect (CPE) including rounding, clumping with cytoplasmic granulation and cluster formation. PCR for the C18L specific BPXV gene was carried out on the virus infected tissue culture produced 368 bp bands. Human infection with BPXV was also recorded. It was concluded that BPXV is circulating in Egyptian buffaloes, causing economical losses and infection in contact humans.

2008 ◽  
Vol 24 (7) ◽  
pp. 957-967 ◽  
Author(s):  
Halina Krowicka ◽  
James E. Robinson ◽  
Rebecca Clark ◽  
Shannon Hager ◽  
Stephanie Broyles ◽  
...  

Cancer ◽  
1958 ◽  
Vol 11 (6) ◽  
pp. 1236-1241 ◽  
Author(s):  
Lewis L. Coriell ◽  
Robert M. McAllister ◽  
Bernard M. Wagner ◽  
Sheldon R. Wilson ◽  
Selena A. Dwight

1978 ◽  
Vol 130 (4) ◽  
pp. 487-496 ◽  
Author(s):  
J.C. Porter ◽  
Richard H. Nalick ◽  
Frank Vellios ◽  
William B. Neaves ◽  
P.C. MacDonald

2009 ◽  
Vol 14 (9) ◽  
pp. 1134-1141 ◽  
Author(s):  
Justin A. Wetter ◽  
Chetana Revankar ◽  
Bonnie J. Hanson

Cellular assay development for the endothelial differentiation gene (EDG) family of G-protein-coupled receptors (GPCRs) and related lysophospholipid (LP) receptors is complicated by endogenous receptor expression and divergent receptor signaling. Endogenously expressed LP receptors exist in most tissue culture cell lines. these LP receptors, along with other endogenously expressed GPCRs, contribute to off-target signaling that can complicate interpretation of second-messenger-based cellular assay results. these receptors also activate a diverse and divergent set of cellular signaling pathways, necessitating the use of a variety of assay formats with mismatched procedures and functional readouts. this complicates examination and comparison of these receptors across the entire family. the tango™ technology uses the conserved β-arrestin-dependent receptor deactivation process to allow interrogation of the EDG and related receptors with a single functional assay. this method also isolates the target receptor signal, allowing the use of tissue culture cell lines regardless of their endogenous receptor expression. the authors describe the use of this technique to build cell-based receptor-specific assays for all 8 members of the EDG receptor family as well as the related LPA receptors GPR23, GPR92, and GPR87. In addition, they demonstrate the value of this technology for identification and investigation of functionally selective receptor compounds as demonstrated by the immunosuppressive compound FtY720-P and its action at the EDG1 and EDG3 receptors. ( Journal of Biomolecular Screening 2009:1134-1141)


Sign in / Sign up

Export Citation Format

Share Document